Imbruvica (ibrutinib): Uses, How It Works, and Common Side Effects
1:24
Imbruvica (ibrutinib): Uses, How It Works, and Common Side Effects
651 views9 months ago
YouTubeDrugs.com
Zanubrutinib vs ibrutinib: implications for frontline CLL management
1:45
Zanubrutinib vs ibrutinib: implications for frontline CLL management
48 views3 weeks ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Venetoclax plus ibrutinib delivers durable remissions after BTK inhibitor resistance in CLL
4:40
Venetoclax plus ibrutinib delivers durable remissions after BTK inhibitor resistance in CLL
65 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
How do tumor subclones and T-cell dynamics influence ibrutinib responses in Waldenström’s?
2:23
How do tumor subclones and T-cell dynamics influence ibrutinib responses in Waldenström’s?
33 views1 month ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Real-world treatability with ibrutinib plus venetoclax in patients with CLL
2:54
Real-world treatability with ibrutinib plus venetoclax in patients with CLL
39 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Pirtobrutinib versus ibrutinib in treatment-naïve and R/R CLL: findings from BRUIN-CLL-314
2:54
Pirtobrutinib versus ibrutinib in treatment-naïve and R/R CLL: findings from BRUIN-CLL-314
132 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Key lessons from the ibrutinib era in CLL
2:45
Key lessons from the ibrutinib era in CLL
45 views4 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:09
Real-world ibrutinib plus venetoclax in frontline CLL/SLL: REALITY-WW and REALITY-2 outcomes
48 views5 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:44
Relationship between dose & BTK occupancy with ibrutinib monotherapy in previously untreated CLL
59 views6 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:28
The impact of ibrutinib dose intensity on clinical outcomes of patients with CLL: EVIdeNCE study
31 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:31
Case report: the continued efficacy of low-dose ibrutinib for CLL after 10 years of treatment
101 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:20
Managing the cardiac off-target side effects associated with ibrutinib treatment
37 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
3:25
A comparative analysis of the efficacy of ibrutinib vs acalabrutinib in fixed-duration CLL therapy
75 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:54
Final report of a Phase II study of venetoclax and ibrutinib in previously untreated WM
74 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:31
MAIC of ibrutinib versus other covalent BTK inhibitors in frontline CLL treatment
138 views1 year ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
7:15
MRD-guided treatment with ibrutinib and other agents in previously untreated CLL: analyses of FLAIR
79 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
1:39
MRD-guided ibrutinib-venetoclax versus ibrutinib or FCR for previously untreated CLL: FLAIR trial
53 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
2:01
Factors affecting the dose of ibrutinib administered to patients with CLL
127 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
See more
Static thumbnail place holder